Home / General / Experimental Novartis Radiopharma Drug Shows Promise in Early Study

Experimental Novartis Radiopharma Drug Shows Promise in Early Study

US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.

By Bhanvi Satija
May 31 (Reuters) – Novartis said on Sunday that ⁠early ⁠data from its experimental actinium-based ⁠drug showed signs of anti-tumour activity against prostate cancer, including in patients ​previously treated with its older drug Pluvi… [2392 chars]

Source: U.S. News & World Report | Published: 2026-05-31T11:16:00Z

Credit: U.S. News & World Report

Tagged: